Part A. Introduction
1. Introduction to the inquiry
2. The patent system and the nature of reform
3. Economic, social and ethical dimensions
Part B. Patent laws and practices
4. International legal framework
5. Domestic legal framework
6. Patentability of genetic materials and technologies
7. Exclusions from patentability
8. Patent office practices
9. Challenging and enforcing patents rights
10. Jurisdictional issues
Part C. Patents and genetic research
11. Funding for research and development
12. Publicly funded research and intellectual property
13. Patents and human genetic research
14. Experitmental and research use defences
15. Research culture, patents and commercialisation
16. Stem cell technologies
Part D. Patents and commercialisation of biotechnology
17. Overview of the biotechnology industry
18. Technology transfer from publicly funded research institutions
19. Patents and the biotechnology industry
Part E. Patents and human health
20. Gene patents and the healthcare system
21. Gene patents and healthcare provision
22. Medical treatment defence
Part F. Licensing and commercial arrangements
23. Licensing of patent rights
24. Patents and competition law
25. Prices surveillance
Part G. Non-voluntary uses
26. Crown use and acquisition
27. Compulsory licensing
28. Statutory licensing scheme
Part H. Other intellectual property issues 29. Copyright, trade secrets and designs
30. Protection of genetic databases
Appendix 1. List of submission; Appendix 2. Abbreviations; Appendix 3. Glossary.